Edelman M - Search Results

1

A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial.

Gitlitz BJ, Tsao-Wei DD, Groshen S, Davies A, Koczywas M, Belani CP, Argiris A, Ramalingam S, Vokes EE, Edelman M, Hoffman P, Ballas MS, Liu SV, Gandara DR. Gitlitz BJ, et al. Among authors: edelman m. J Thorac Oncol. 2012 Mar;7(3):574-8. doi: 10.1097/JTO.0b013e31823f43ca. J Thorac Oncol. 2012. PMID: 22198425 Free PMC article. Clinical Trial.

2

Promising new agents in the treatment of non-small cell lung cancer.

Edelman MJ, Gandara DR. Edelman MJ, et al. Cancer Chemother Pharmacol. 1996;37(5):385-93. doi: 10.1007/s002800050402. Cancer Chemother Pharmacol. 1996. PMID: 8599859 Review.

3

Multimodality therapy in stage III non-small cell lung cancer.

Edelman MJ, Gandara DR, Roach M 3rd, Benfield JR. Edelman MJ, et al. Ann Thorac Surg. 1996 May;61(5):1564-72. doi: 10.1016/0003-4975(96)00044-6. Ann Thorac Surg. 1996. PMID: 8633990 Review.

4

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study.

Gandara DR, Edelman MJ, Crowley JJ, Lau DH, Livingston RB. Gandara DR, et al. Among authors: edelman mj. Cancer Chemother Pharmacol. 1997;41(1):75-8. doi: 10.1007/s002800050710. Cancer Chemother Pharmacol. 1997. PMID: 9443617 Clinical Trial.

5

Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administration.

Gandara DR, Roila F, Warr D, Edelman MJ, Perez EA, Gralla RJ. Gandara DR, et al. Among authors: edelman mj. Support Care Cancer. 1998 May;6(3):237-43. doi: 10.1007/s005200050160. Support Care Cancer. 1998. PMID: 9629876 Review.

6

Small cell lung cancer: current status of new chemotherapeutic agents.

Edelman MJ, Gandara DR. Edelman MJ, et al. Crit Rev Oncol Hematol. 1998 Apr;27(3):211-20. doi: 10.1016/s1040-8428(98)00002-x. Crit Rev Oncol Hematol. 1998. PMID: 9649933 Review. No abstract available.

7

Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy.

Edelman MJ, Gandara DR, Perez EA, Lau D, Lauder I, Turrell C, Uhrich M, Meyers F. Edelman MJ, et al. Invest New Drugs. 1998;16(1):69-75. doi: 10.1023/a:1006026928733. Invest New Drugs. 1998. PMID: 9740546 Clinical Trial.

8

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically.

Lara PN Jr, Gandara DR, Wurz GT, Lau D, Uhrich M, Turrell C, Raschko J, Edelman MJ, Synold T, Doroshow J, Muggia F, Perez EA, DeGregorio M. Lara PN Jr, et al. Among authors: edelman mj. Cancer Chemother Pharmacol. 1998;42(6):504-8. doi: 10.1007/s002800050852. Cancer Chemother Pharmacol. 1998. PMID: 9788578 Clinical Trial.

9

Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancer.

Langer CJ, Gandara DR, Calvert P, Edelman MJ, Ozols RF. Langer CJ, et al. Among authors: edelman mj. Semin Oncol. 1999 Feb;26(1 Suppl 4):12-8. Semin Oncol. 1999. PMID: 10201516 Review.

10

Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer.

Gandara DR, Edelman MJ, Lau D. Gandara DR, et al. Among authors: edelman mj. Semin Oncol. 1999 Jun;26(3 Suppl 10):3-7. Semin Oncol. 1999. PMID: 10437743 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

557 results

Search Page

Filters